Agilent Technologies (A) Gross Profit Margin: History & Chart

Agilent Technologies, Inc.(A)

Medical - Diagnostics & Research · Santa Clara, CA

$144.78+0.00 (+0.00%)

Delayed quote: Sep 9, 2026, 3:59 PM EDT

About Agilent Technologies, Inc.

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

Santa Clara, CA

18,000 employees

www.agilent.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Padraig McDonnell

View full financials

A Gross Margin Metrics

GROSS MARGIN

53.73%

GROSS MARGIN AVG TTM

53.49%

GROSS MARGIN AVG 3Y

53.69%

GROSS MARGIN AVG 5Y

53.92%

GROSS MARGIN AVG 10Y

53.88%

GROSS MARGIN AVG 15Y

53.15%

GROSS MARGIN AVG 20Y

53.37%

CURRENT VS TTM AVG

+0.44%

CURRENT VS 3Y AVG

+0.07%

CURRENT VS 5Y AVG

-0.36%

CURRENT VS 10Y AVG

-0.27%

CURRENT VS 15Y AVG

+1.10%

CURRENT VS 20Y AVG

+0.68%

SECTOR MEDIAN · HEALTHCARE

58.99%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

-8.92%

vs the sector median at left

NAME	MARKET CAP	GROSS MARGIN	TTM	3Y	5Y
Agilent Technologies, Inc. (A)	$40.89B	53.73%	53.49%	53.69%	53.92%
IDEXX Laboratories, Inc. (IDXX)vs ›	$40.64B	62.45%	61.42%	60.55%	59.83%
IQVIA Holdings Inc. (IQV)vs ›	$42.30B	26.23%	30.59%	32.75%	33.07%
Teva Pharmaceutical Industries Limited (TEVA)vs ›	$42.92B	52.47%	50.27%	48.88%	48.29%
Alnylam Pharmaceuticals, Inc. (ALNY)vs ›	$34.52B	79.72%	83.69%	83.53%	83.62%
Humana Inc. (HUM)vs ›	$48.03B	13.65%	14.54%	16.14%	17.03%
Alcon Inc. (ALC)vs ›	$33.37B	56.45%	55.42%	55.20%	53.33%
Becton, Dickinson and Company (BDX)vs ›	$49.54B	46.12%	45.33%	44.44%	44.19%
Edwards Lifesciences Corporation (EW)vs ›	$49.62B	77.98%	78.79%	78.80%	77.78%
ResMed Inc. (RMD)vs ›	$31.91B	61.16%	60.26%	58.24%	57.85%

NAME

MARKET CAP

GROSS MARGIN

TTM

Agilent Technologies, Inc. (A)

$40.89B

53.73%

53.49%

53.69%

53.92%

IDEXX Laboratories, Inc. (IDXX)vs ›

$40.64B

62.45%

61.42%

60.55%

59.83%

IQVIA Holdings Inc. (IQV)vs ›

$42.30B

26.23%

30.59%

32.75%

33.07%

Teva Pharmaceutical Industries Limited (TEVA)vs ›

$42.92B

52.47%

50.27%

48.88%

48.29%

Alnylam Pharmaceuticals, Inc. (ALNY)vs ›

$34.52B

79.72%

83.69%

83.53%

83.62%

Humana Inc. (HUM)vs ›

$48.03B

13.65%

14.54%

16.14%

17.03%

Alcon Inc. (ALC)vs ›

$33.37B

56.45%

55.42%

55.20%

53.33%

Becton, Dickinson and Company (BDX)vs ›

$49.54B

46.12%

45.33%

44.44%

44.19%

Edwards Lifesciences Corporation (EW)vs ›

$49.62B

77.98%

78.79%

78.80%

77.78%

ResMed Inc. (RMD)vs ›

$31.91B

61.16%

60.26%

58.24%

57.85%

Gross Margin FAQ

What is the gross margin for Agilent Technologies, Inc. (A)?

The gross margin for A stock is 53.73%.

Is Agilent Technologies, Inc.'s gross margin high or low?

The gross margin of 53.73% is in line with its 5-year average of 53.92%, near the high end of its 5-year range (39.35%–55.48%).

What is the TTM average gross margin for Agilent Technologies, Inc. (A)?

The TTM average gross margin for A stock is 53.49%.

What is the 3Y average gross margin for Agilent Technologies, Inc. (A)?

The 3Y average gross margin for A stock is 53.69%.

What is the 5Y average gross margin for Agilent Technologies, Inc. (A)?

The 5Y average gross margin for A stock is 53.92%.

What is the 10Y average gross margin for Agilent Technologies, Inc. (A)?

The 10Y average gross margin for A stock is 53.88%.

What is the 15Y average gross margin for Agilent Technologies, Inc. (A)?

The 15Y average gross margin for A stock is 53.15%.

What is the 20Y average gross margin for Agilent Technologies, Inc. (A)?

The 20Y average gross margin for A stock is 53.37%.

DATE	GROSS MARGIN
2026-07-31	55.48%
2026-04-30	54.99%
2026-01-31	52.61%
2025-10-31	51.80%
2025-07-31	52.59%
2025-04-30	51.92%
2025-01-31	53.48%
2024-10-31	53.85%
2024-07-31	54.18%
2024-04-30	54.42%
2024-01-31	54.76%
2023-10-31	54.21%
2023-07-31	39.35%
2023-04-30	53.81%
2023-01-31	55.13%
2022-10-31	54.73%
2022-07-31	54.66%
2022-04-30	53.58%
2022-01-31	54.36%
2021-10-31	54.22%
2021-07-31	53.72%
2021-04-30	53.57%
2021-01-31	54.13%
2020-10-31	53.14%
2020-07-31	53.05%
2020-04-30	53.07%
2020-01-31	53.28%
2019-10-31	53.91%
2019-07-31	54.32%
2019-04-30	54.04%
2019-01-31	55.06%
2018-10-31	54.79%
2018-07-31	54.95%
2018-04-30	53.40%
2018-01-31	55.57%
2017-10-31	54.42%
2017-07-31	53.50%
2017-04-30	53.72%
2017-01-31	53.80%
2016-10-31	52.93%
2016-07-31	51.92%
2016-04-30	52.01%
2016-01-31	52.24%
2015-10-31	51.69%
2015-07-31	50.59%
2015-04-30	49.84%
2015-01-31	50.00%
2014-10-31	45.93%
2014-07-31	49.75%
2014-04-30	49.09%
2014-01-31	50.60%
2013-10-31	52.85%
2013-07-31	51.82%
2013-04-30	51.44%
2013-01-31	52.38%
2012-10-31	52.18%
2012-07-31	51.65%
2012-04-30	52.97%
2012-01-31	53.46%
2011-10-31	53.30%
2011-07-31	52.75%
2011-04-30	53.67%
2011-01-31	53.72%
2010-10-31	52.92%
2010-07-31	52.38%
2010-04-30	55.94%
2010-01-31	54.41%
2009-10-31	54.33%
2009-07-31	50.99%
2009-04-30	48.58%
2009-01-31	50.51%
2008-10-31	56.04%
2008-07-31	55.61%
2008-04-30	55.43%
2008-01-31	54.27%
2007-10-31	54.63%
2007-07-31	55.17%
2007-04-30	55.30%
2007-01-31	53.98%
2006-10-31	60.56%
2006-07-31	54.44%
2006-04-30	51.15%
2006-01-31	50.82%
2005-10-31	205.71%
2005-07-31	45.32%
2005-04-30	46.80%
2005-01-31	45.30%
2004-10-31	42.81%
2004-07-31	42.23%
2004-04-30	44.13%
2004-01-31	44.98%
2003-10-31	42.45%
2003-07-31	36.48%
2003-04-30	34.49%
2003-01-31	37.46%
2002-10-31	35.71%

DATE

GROSS MARGIN

2026-07-31

55.48%

2026-04-30

54.99%

2026-01-31

52.61%

2025-10-31

51.80%

2025-07-31

52.59%

2025-04-30

51.92%

2025-01-31

53.48%

2024-10-31

53.85%

2024-07-31

54.18%

2024-04-30

54.42%

2024-01-31

54.76%

2023-10-31

54.21%

2023-07-31

39.35%

2023-04-30

53.81%

2023-01-31

55.13%

2022-10-31

54.73%

2022-07-31

54.66%

2022-04-30

53.58%

2022-01-31

54.36%

2021-10-31

54.22%

2021-07-31

53.72%

2021-04-30

53.57%

2021-01-31

54.13%

2020-10-31

53.14%

2020-07-31

53.05%

2020-04-30

53.07%

2020-01-31

53.28%

2019-10-31

53.91%

2019-07-31

54.32%

2019-04-30

54.04%

2019-01-31

55.06%

2018-10-31

54.79%

2018-07-31

54.95%

2018-04-30

53.40%

2018-01-31

55.57%

2017-10-31

54.42%

2017-07-31

53.50%

2017-04-30

53.72%

2017-01-31

53.80%

2016-10-31

52.93%

2016-07-31

51.92%

2016-04-30

52.01%

2016-01-31

52.24%

2015-10-31

51.69%

2015-07-31

50.59%

2015-04-30

49.84%

2015-01-31

50.00%

2014-10-31

45.93%

2014-07-31

49.75%

2014-04-30

49.09%

2014-01-31

50.60%

2013-10-31

52.85%

2013-07-31

51.82%

2013-04-30

51.44%

2013-01-31

52.38%

2012-10-31

52.18%

2012-07-31

51.65%

2012-04-30

52.97%

2012-01-31

53.46%

2011-10-31

53.30%

2011-07-31

52.75%

2011-04-30

53.67%

2011-01-31

53.72%

2010-10-31

52.92%

2010-07-31

52.38%

2010-04-30

55.94%

2010-01-31

54.41%

2009-10-31

54.33%

2009-07-31

50.99%

2009-04-30

48.58%

2009-01-31

50.51%

2008-10-31

56.04%

2008-07-31

55.61%

2008-04-30

55.43%

2008-01-31

54.27%

2007-10-31

54.63%

2007-07-31

55.17%

2007-04-30

55.30%

2007-01-31

53.98%

2006-10-31

60.56%

2006-07-31

54.44%

2006-04-30

51.15%

2006-01-31

50.82%

2005-10-31

205.71%

2005-07-31

45.32%

2005-04-30

46.80%

2005-01-31

45.30%

2004-10-31

42.81%

2004-07-31

42.23%

2004-04-30

44.13%

2004-01-31

44.98%

2003-10-31

42.45%

2003-07-31

36.48%

2003-04-30

34.49%

2003-01-31

37.46%

2002-10-31

35.71%

Gross Margin: 53.73%

A Gross Margin

A Average Gross Margin Chart

A Current vs Average Gross Margin Chart

A Gross Margin Metrics

A Competitors' Gross Margin

Gross Margin Analysis

Gross Margin Formula & Definition

Gross Margin FAQ

A Gross Margin History

Related Metrics